Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study

This research assesses whether multi-year treatment with antipsychotic medications reduces or eliminates psychosis in schizophrenia. It provides 20 years of longitudinal data on the frequency and severity of psychotic activity in samples of schizophrenia patients (SZ) treated versus those not treate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychological medicine 2014-10, Vol.44 (14), p.3007-3016
Hauptverfasser: Harrow, M., Jobe, T. H., Faull, R. N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3016
container_issue 14
container_start_page 3007
container_title Psychological medicine
container_volume 44
creator Harrow, M.
Jobe, T. H.
Faull, R. N.
description This research assesses whether multi-year treatment with antipsychotic medications reduces or eliminates psychosis in schizophrenia. It provides 20 years of longitudinal data on the frequency and severity of psychotic activity in samples of schizophrenia patients (SZ) treated versus those not treated with antipsychotic medications. A total of 139 early young schizophrenia and mood-disordered patients were assessed at index hospitalization and then reassessed six times over 20 years for psychosis and other major variables. At each follow-up assessment over the 20 years, a surprisingly high percentage of SZ treated with antipsychotics longitudinally had psychotic activity. More than 70% of SZ continuously prescribed antipsychotics experienced psychotic activity at four or more of six follow-up assessments over 20 years. Longitudinally, SZ not prescribed antipsychotics showed significantly less psychotic activity than those prescribed antipsychotics (p < 0.05). The 20-year data indicate that, longitudinally, after the first few years, antipsychotic medications do not eliminate or reduce the frequency of psychosis in schizophrenia, or reduce the severity of post-acute psychosis, although it is difficult to reach unambiguous conclusions about the efficacy of treatment in purely naturalistic or observational research. Longitudinally, on the basis of their psychotic activity and the disruption of functioning, the condition of the majority of SZ prescribed antipsychotics for multiple years would raise questions as to how many of them are truly in remission.
doi_str_mv 10.1017/S0033291714000610
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566830806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291714000610</cupid><sourcerecordid>1566830806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-29e10bbb208219c04b3ce3896d6241d6fa0f49c4af503010fb669bf02457a4b33</originalsourceid><addsrcrecordid>eNqNkU2LFDEQhoMo7jj6A7xIQIS9tFYl6aRzkmVdP2DBg3pu0unEydLdaZM0ywj-d3uY8QNF8FDUoZ6qt6peQh4jPEdA9eIDAOdMo0IBABLhDtmgkLpqtGruks2hXB3qZ-RBzjcAyFGw--SM1SCl0mxDvr2KLtOSnCmjmwqNnma7C1_jvEtuCobehrKjZiphznu7iyVYOro-WFNCnDJ1QxjDZIqjMdHk-sU6eiRzyC_pBWVQ7Z1JdFyGEiofhyHeVstMc1n6_UNyz5shu0envCWfXl99vHxbXb9_8-7y4rqytZJlPcEhdF3HoGGoLYiOW8cbLXvJBPbSG_BCW2F8DRwQfCel7jwwUSuzwnxLzo9z5xS_LC6XdgzZumEwk4tLbrGWsuHQgPwPtG5qxvUaW_L0D_QmLmlaD2lRgq5RCn7QxiNlU8w5Od_OKYwm7VuE9mBj-5eNa8-T0-SlW7_9s-OHbyvw7ASYbM3gk5lsyL-4RqlarXZvCT-Jm7FLof_sftvxn_LfAeFls6k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1609516433</pqid></control><display><type>article</type><title>Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study</title><source>MEDLINE</source><source>Cambridge Journals</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><creator>Harrow, M. ; Jobe, T. H. ; Faull, R. N.</creator><creatorcontrib>Harrow, M. ; Jobe, T. H. ; Faull, R. N.</creatorcontrib><description>This research assesses whether multi-year treatment with antipsychotic medications reduces or eliminates psychosis in schizophrenia. It provides 20 years of longitudinal data on the frequency and severity of psychotic activity in samples of schizophrenia patients (SZ) treated versus those not treated with antipsychotic medications. A total of 139 early young schizophrenia and mood-disordered patients were assessed at index hospitalization and then reassessed six times over 20 years for psychosis and other major variables. At each follow-up assessment over the 20 years, a surprisingly high percentage of SZ treated with antipsychotics longitudinally had psychotic activity. More than 70% of SZ continuously prescribed antipsychotics experienced psychotic activity at four or more of six follow-up assessments over 20 years. Longitudinally, SZ not prescribed antipsychotics showed significantly less psychotic activity than those prescribed antipsychotics (p &lt; 0.05). The 20-year data indicate that, longitudinally, after the first few years, antipsychotic medications do not eliminate or reduce the frequency of psychosis in schizophrenia, or reduce the severity of post-acute psychosis, although it is difficult to reach unambiguous conclusions about the efficacy of treatment in purely naturalistic or observational research. Longitudinally, on the basis of their psychotic activity and the disruption of functioning, the condition of the majority of SZ prescribed antipsychotics for multiple years would raise questions as to how many of them are truly in remission.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291714000610</identifier><identifier>PMID: 25066792</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adult ; Adult and adolescent clinical studies ; Antipsychotic Agents - pharmacology ; Biological and medical sciences ; Clinical outcomes ; Follow-Up Studies ; Humans ; Medical sciences ; Mood Disorders - drug therapy ; Neuropharmacology ; Original Articles ; Outcome Assessment (Health Care) ; Pharmacology. Drug treatments ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Psychoses ; Psychosis ; Psychotic Disorders - drug therapy ; Psychotropic drugs ; Schizophrenia ; Schizophrenia - drug therapy ; Time Factors</subject><ispartof>Psychological medicine, 2014-10, Vol.44 (14), p.3007-3016</ispartof><rights>Copyright © Cambridge University Press 2014</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-29e10bbb208219c04b3ce3896d6241d6fa0f49c4af503010fb669bf02457a4b33</citedby><cites>FETCH-LOGICAL-c576t-29e10bbb208219c04b3ce3896d6241d6fa0f49c4af503010fb669bf02457a4b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291714000610/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,12846,27924,27925,30999,55628</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28775701$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25066792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harrow, M.</creatorcontrib><creatorcontrib>Jobe, T. H.</creatorcontrib><creatorcontrib>Faull, R. N.</creatorcontrib><title>Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>This research assesses whether multi-year treatment with antipsychotic medications reduces or eliminates psychosis in schizophrenia. It provides 20 years of longitudinal data on the frequency and severity of psychotic activity in samples of schizophrenia patients (SZ) treated versus those not treated with antipsychotic medications. A total of 139 early young schizophrenia and mood-disordered patients were assessed at index hospitalization and then reassessed six times over 20 years for psychosis and other major variables. At each follow-up assessment over the 20 years, a surprisingly high percentage of SZ treated with antipsychotics longitudinally had psychotic activity. More than 70% of SZ continuously prescribed antipsychotics experienced psychotic activity at four or more of six follow-up assessments over 20 years. Longitudinally, SZ not prescribed antipsychotics showed significantly less psychotic activity than those prescribed antipsychotics (p &lt; 0.05). The 20-year data indicate that, longitudinally, after the first few years, antipsychotic medications do not eliminate or reduce the frequency of psychosis in schizophrenia, or reduce the severity of post-acute psychosis, although it is difficult to reach unambiguous conclusions about the efficacy of treatment in purely naturalistic or observational research. Longitudinally, on the basis of their psychotic activity and the disruption of functioning, the condition of the majority of SZ prescribed antipsychotics for multiple years would raise questions as to how many of them are truly in remission.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Clinical outcomes</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mood Disorders - drug therapy</subject><subject>Neuropharmacology</subject><subject>Original Articles</subject><subject>Outcome Assessment (Health Care)</subject><subject>Pharmacology. Drug treatments</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Psychoses</subject><subject>Psychosis</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><subject>Time Factors</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkU2LFDEQhoMo7jj6A7xIQIS9tFYl6aRzkmVdP2DBg3pu0unEydLdaZM0ywj-d3uY8QNF8FDUoZ6qt6peQh4jPEdA9eIDAOdMo0IBABLhDtmgkLpqtGruks2hXB3qZ-RBzjcAyFGw--SM1SCl0mxDvr2KLtOSnCmjmwqNnma7C1_jvEtuCobehrKjZiphznu7iyVYOro-WFNCnDJ1QxjDZIqjMdHk-sU6eiRzyC_pBWVQ7Z1JdFyGEiofhyHeVstMc1n6_UNyz5shu0envCWfXl99vHxbXb9_8-7y4rqytZJlPcEhdF3HoGGoLYiOW8cbLXvJBPbSG_BCW2F8DRwQfCel7jwwUSuzwnxLzo9z5xS_LC6XdgzZumEwk4tLbrGWsuHQgPwPtG5qxvUaW_L0D_QmLmlaD2lRgq5RCn7QxiNlU8w5Od_OKYwm7VuE9mBj-5eNa8-T0-SlW7_9s-OHbyvw7ASYbM3gk5lsyL-4RqlarXZvCT-Jm7FLof_sftvxn_LfAeFls6k</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Harrow, M.</creator><creator>Jobe, T. H.</creator><creator>Faull, R. N.</creator><general>Cambridge University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study</title><author>Harrow, M. ; Jobe, T. H. ; Faull, R. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-29e10bbb208219c04b3ce3896d6241d6fa0f49c4af503010fb669bf02457a4b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Clinical outcomes</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mood Disorders - drug therapy</topic><topic>Neuropharmacology</topic><topic>Original Articles</topic><topic>Outcome Assessment (Health Care)</topic><topic>Pharmacology. Drug treatments</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Psychoses</topic><topic>Psychosis</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harrow, M.</creatorcontrib><creatorcontrib>Jobe, T. H.</creatorcontrib><creatorcontrib>Faull, R. N.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harrow, M.</au><au>Jobe, T. H.</au><au>Faull, R. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>44</volume><issue>14</issue><spage>3007</spage><epage>3016</epage><pages>3007-3016</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>This research assesses whether multi-year treatment with antipsychotic medications reduces or eliminates psychosis in schizophrenia. It provides 20 years of longitudinal data on the frequency and severity of psychotic activity in samples of schizophrenia patients (SZ) treated versus those not treated with antipsychotic medications. A total of 139 early young schizophrenia and mood-disordered patients were assessed at index hospitalization and then reassessed six times over 20 years for psychosis and other major variables. At each follow-up assessment over the 20 years, a surprisingly high percentage of SZ treated with antipsychotics longitudinally had psychotic activity. More than 70% of SZ continuously prescribed antipsychotics experienced psychotic activity at four or more of six follow-up assessments over 20 years. Longitudinally, SZ not prescribed antipsychotics showed significantly less psychotic activity than those prescribed antipsychotics (p &lt; 0.05). The 20-year data indicate that, longitudinally, after the first few years, antipsychotic medications do not eliminate or reduce the frequency of psychosis in schizophrenia, or reduce the severity of post-acute psychosis, although it is difficult to reach unambiguous conclusions about the efficacy of treatment in purely naturalistic or observational research. Longitudinally, on the basis of their psychotic activity and the disruption of functioning, the condition of the majority of SZ prescribed antipsychotics for multiple years would raise questions as to how many of them are truly in remission.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>25066792</pmid><doi>10.1017/S0033291714000610</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-2917
ispartof Psychological medicine, 2014-10, Vol.44 (14), p.3007-3016
issn 0033-2917
1469-8978
language eng
recordid cdi_proquest_miscellaneous_1566830806
source MEDLINE; Cambridge Journals; Applied Social Sciences Index & Abstracts (ASSIA)
subjects Adult
Adult and adolescent clinical studies
Antipsychotic Agents - pharmacology
Biological and medical sciences
Clinical outcomes
Follow-Up Studies
Humans
Medical sciences
Mood Disorders - drug therapy
Neuropharmacology
Original Articles
Outcome Assessment (Health Care)
Pharmacology. Drug treatments
Psycholeptics: tranquillizer, neuroleptic
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Psychoses
Psychosis
Psychotic Disorders - drug therapy
Psychotropic drugs
Schizophrenia
Schizophrenia - drug therapy
Time Factors
title Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A43%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20treatment%20of%20schizophrenia%20with%20antipsychotic%20medications%20eliminate%20or%20reduce%20psychosis?%20A%2020-year%20multi-follow-up%20study&rft.jtitle=Psychological%20medicine&rft.au=Harrow,%20M.&rft.date=2014-10-01&rft.volume=44&rft.issue=14&rft.spage=3007&rft.epage=3016&rft.pages=3007-3016&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291714000610&rft_dat=%3Cproquest_cross%3E1566830806%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1609516433&rft_id=info:pmid/25066792&rft_cupid=10_1017_S0033291714000610&rfr_iscdi=true